| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724780 | (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 | 0.0304779558345021 | 0.1427411 |
| NSC 732517 | Dasatinib | 0.0304779558345021 | -0.058660395 |
| NSC 736079 | 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine | 0.0304779558345021 | -0.042707206 |
| NSC 736153 | Null | 0.0304779558345021 | 0.11518377 |
| NSC 118994 | Inosine dialdehyde | 0.0366216145653018 | 0.20898028 |
| NSC 711885 | Null | 0.0366216145653018 | 0.14533165 |
| NSC 716261 | Null | 0.0366216145653018 | -0.14332958 |
| NSC 736443 | 7-fluoro-2-(2-furoyl)-3-trifluoromethylquioxaline 1,4-dioxide | 0.0366216145653018 | 0.19510872 |
| NSC 123463 | Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) | 0.0386895225700407 | -0.05474711 |
| NSC 135929 | Null | 0.0386895225700407 | 0.16704474 |